Pierre G. Coulie
Pierre G. Coulie
Email verificata su uclouvain.be
Titolo
Citata da
Citata da
Anno
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
V Brichard, A Van Pel, T Wölfel, C Wölfel, E De Plaen, B Lethé, P Coulie, ...
The Journal of experimental medicine 178 (2), 489-495, 1993
11491993
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
PG Coulie, V Brichard, A Van Pel, T Wölfel, J Schneider, C Traversari, ...
The Journal of experimental medicine 180 (1), 35-42, 1994
11161994
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1
M Marchand, N Van Baren, P Weynants, V Brichard, B Dréno, MH Tessier, ...
International journal of cancer 80 (2), 219-230, 1999
10241999
Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas
J Van Snick, S Cayphas, A Vink, C Uyttenhove, PG Coulie, MR Rubira, ...
Proceedings of the National Academy of Sciences 83 (24), 9679-9683, 1986
7921986
Human T cell responses against melanoma
T Boon, PG Coulie, BJV Eynde, P Bruggen
Annu. Rev. Immunol. 24, 175-208, 2006
7572006
Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
H Ikeda, B Lethé, F Lehmann, N Van Baren, JF Baurain, C De Smet, ...
Immunity 6 (2), 199-208, 1997
7361997
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
P Boël, C Wildmann, ML Sensi, R Brasseur, JC Renauld, P Coulie, ...
Immunity 2 (2), 167-175, 1995
7251995
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
PG Coulie, BJ Van den Eynde, P Van Der Bruggen, T Boon
Nature Reviews Cancer 14 (2), 135-146, 2014
7182014
Tumor antigens recognized by T cells
T Boon, PG Coulie, B Van den Eynde
Immunology today 18 (6), 267-268, 1997
6561997
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, M Akdis, I Andrä, F Annunziato, ...
European journal of immunology 47 (10), 1584-1797, 2017
5412017
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma
PG Coulie, F Lehmann, B Lethe, J Herman, C Lurquin, M Andrawiss, ...
Proceedings of the National Academy of Sciences 92 (17), 7976-7980, 1995
4401995
A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3
P van der Bruggen, J Bastin, T Gajewski, PG Coulie, P Boël, C De Smet, ...
European journal of immunology 24 (12), 3038-3043, 1994
4401994
The determinants of tumour immunogenicity
T Blankenstein, PG Coulie, E Gilboa, EM Jaffee
Nature Reviews Cancer 12 (4), 307-313, 2012
3042012
T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor.
C Uyttenhove, PG Coulie, J Van Snick
The Journal of experimental medicine 167 (4), 1417-1427, 1988
3001988
A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia
H Dolstra, H Fredrix, F Maas, PG Coulie, F Brasseur, E Mensink, ...
The Journal of experimental medicine 189 (2), 301-308, 1999
2851999
Genes coding for tumor antigens recognized by cytolytic T lymphocytes
A Van Pel, P Van Der Bruggen, PG Coulie, VG Brichard, B Lethe
Immunological reviews 145, 229-250, 1995
2811995
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3
PG Coulie, V Karanikas, D Colau, C Lurquin, C Landry, M Marchand, ...
Proceedings of the National Academy of Sciences 98 (18), 10290-10295, 2001
2742001
Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients
J Tel, EHJG Aarntzen, T Baba, G Schreibelt, BM Schulte, D Benitez-Ribas, ...
Cancer research 73 (3), 1063-1075, 2013
2662013
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection
F Lehmann, M Marchand, P Hainaut, P Pouillart, X Sastre, H Ikeda, ...
European journal of immunology 25 (2), 340-347, 1995
2611995
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen
C Lurquin, B Lethé, E De Plaen, V Corbière, I Théate, N Van Baren, ...
The Journal of experimental medicine 201 (2), 249-257, 2005
2592005
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20